New research shows that use of real-time continuous glucose monitoring (CGM) produces significant long-term improvement in HbA1c in adult patients with type 1 diabetes. The benefit is present whether the patients  use insulin pumps or multiple daily insulin injections (MDI). In the study, patients had HbA1c reductions from 8.2% to 7.1% in the pump/CGM group and 8.5% to 7.2% in the MDI/CGM group. Read more